Metagenomi Therapeutics (MGX) Asset Utilization Ratio (2024 - 2026)
Metagenomi Therapeutics (MGX) reported Asset Utilization Ratio of 0.11 for Q1 2026, down 26.54% year-over-year from 0.15 in Q1 2025, and down 0.62% quarter-over-quarter from 0.11 in Q4 2025.
Metagenomi Therapeutics (MGX) Asset Utilization Ratio (2024 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 3 years of Asset Utilization Ratio data on file, last reported at 0.11 in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.11, down 26.54% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.11 (down 26.54% YoY), and the FY2025 annual result was 0.09, down 39.09% from the prior year.
- Asset Utilization Ratio retreated to 0.11 in Q1 2026 per MGX's latest filing, from 0.11 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.15 in Q4 2024 and troughed at 0.11 in Q1 2026.
- A 3-year average of 0.13 and a median of 0.12 in 2024 frame the typical range for Asset Utilization Ratio.
- On a YoY basis, Asset Utilization Ratio climbed as much as 20.06% in 2025 and fell as far as 29.81% in 2025.
- A 3-year view of Asset Utilization Ratio shows it stood at 0.15 in 2024, then fell by 29.81% to 0.11 in 2025, then dropped by 0.62% to 0.11 in 2026.
- Business Quant data shows MGX's Asset Utilization Ratio at 0.11 in Q1 2026, 0.11 in Q4 2025, and 0.12 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | 0.55 |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | 0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.11 |
| Dec 31, 2025 | 0.11 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | 0.15 |
| Dec 31, 2024 | 0.15 |
| Sep 30, 2024 | 0.15 |
| Jun 30, 2024 | 0.14 |
| Mar 31, 2024 | 0.12 |